Maximal oxygen uptake (V˙O2max), which, in a way, represents endurance performance, is, according to Fick's equation, determined by the oxygen supply of the blood and by the oxygen consumption of the skeletal muscle. Depending on the performance state, one of the two factors gains importance. It has been shown that, in untrained subjects, the oxygen consumption dominates V˙O2max, whereas in endurance-trained athletes, the oxygen supply is the main limiting factor (16,33).
The oxygen transport to the muscle underlies a complex regulation, which depends on hemoglobin concentration ([Hb]) and muscle perfusion. The latter adapts to the actual metabolic situation and can be modulated by a systemic or local regulation of the vascular diameter as well as by a change in cardiac output ((CO); for review, see (25)). The most important factor for a high CO is a compliant heart and a distensible pericardium (16), which permits a high end diastolic volume and herewith a high stroke volume. Furthermore, an efficient muscle pump (25) and a fast diastolic filling (for review, see (16)) is prerequisite, which, however, is only possible with an adequate high blood volume. Therefore, an augmentation of blood volume leads to a higher CO and an increase in V˙O2max, provided that [Hb] is high enough.
Therefore, under normoxic conditions, V˙O2max mainly depends on CO and [Hb]. In hypoxia, however, the prevailing oxygen (O2) partial pressure gains importance, and the O2 diffusion rate in the lungs and the skeletal muscle become the limiting factor (33).
In this context, hemoglobin mass (tHb-mass) is important in two ways. On one side, its total mass in combination with the total volume of blood determines [Hb] and herewith O2 transport capacity. On the other side, it increases blood volume via the increase in erythrocyte volume. This double role explains the higher correlation with V˙O2max compared with blood volume or [Hb] (15).
The relationship between blood volume and tHb-mass and the influence of both parameters on [Hb] are illustrated in Figure 1. It is obvious that tHb-mass linearly depends on blood volume over a broad range in a sex-related manner. The scattering of tHb-mass related to a certain value of blood volume reflects different [Hb]. [Hb] and tHb-mass are therefore different physiological parameters, which may exert different effects on endurance performance.
Because of methodological issues related to tHb-mass determination, it has been difficult for a long time to determine the contributions of tHb-mass versus [Hb] to parameters such as V˙O2max and endurance performance. With the routine application of the well-known CO-rebreathing method optimized by Burge and Skinner (4) and later on by Schmidt and Prommer (30), new insight regarding the relationship of these parameters with V˙O2max and endurance performance has been gained (30).
We hypothesize that V˙O2max can be increased by two different hematological adaptations. The first involves a balanced increase in blood volume and tHb-mass leading to increased cardiac output, and the second involves a relatively constant blood volume with an increase in tHb-mass resulting in an elevated [Hb] and herewith improved oxygen diffusion. The aim of this article is to distinguish between the effects of tHb-mass and [Hb] on V˙O2max and illustrate how variations of these parameters alter V˙O2max.
TOTAL HEMOGLOBIN MASS AND [Hb] AS CONTRIBUTORS TO V˙O2max
The magnitude of blood volume and tHb-mass correlates well with anthropometric characteristics, that is, especially with lean body mass (LBM) (26). In contrast, [Hb] is not related to LBM (32). It is well known that tHb-mass and blood volume are expanded in elite endurance athletes by up to 50% compared with sedentary subjects (13). Cross-sectional (9) and longitudinal studies (15) clearly demonstrate that V˙O2max is closely related to tHb-mass and blood volume but not [Hb] (Fig. 2). Interestingly, the relationship between V˙O2max and tHb-mass is independent of sex and age.
The underlying mechanism for this close relationship is based on the fact that a high blood volume and its accompanying high tHb-mass can affect venous return and cardiac filling pressures resulting in elevated maximum CO (6,14). A similar relationship between tHb-mass, blood volume, and cardiac output with V˙O2max is demonstrated in Figure 3, showing a parallel increase in the corresponding regression lines. The ratio between CO at maximum exercise and blood volume is approximately 4:1, when considering a broad performance range (V˙O2max between 3 L and 6 L). This ratio indicates that the blood and the hemoglobin molecules circulate four times per minute through the body independent of their absolute volumes. When calculating oxygen transport by the hemoglobin molecule at maximum performance, the change in tHb-mass by 1 g is associated with a change in V˙O2max of approximately 4 mL·min−1 (1 g hemoglobin binds 1.39 mL O2; assumed is: arteriovenous oxygen difference (avDO2) to be 75%, four circulation passages per minute as previously mentioned). This calculated value fits very well with the slope of the regression line obtained between V˙O2max and tHb-mass in Figure 2a as well as with the results described in the literature in cross-sectional studies (9). These considerations demonstrate that high levels of tHb-mass and blood volume are indispensable prerequisites for a high V˙O2max, a key parameter in determining endurance performance success.
With respect to sex-related differences in [Hb] (Fig. 1), no relationship between [Hb] and V˙O2max can be found either in very heterogeneously trained groups (Fig. 2) or within groups characterized by very similar endurance levels (13). For physiological, nonanemic conditions in normoxia, we conclude that the influences of tHb-mass on V˙O2max are greater than that of [Hb]. This conclusion is supported by various studies using plasma volume expansion and reduction demonstrating a closer relationship between V˙O2max and tHb-mass than between V˙O2max and [Hb] or blood volume (15).
The impact of [Hb] on V˙O2max, however, gains importance under nonphysiological conditions, such as blood loss. In this case, the quick recovery of blood volume due to plasma volume expansion coincides with a simultaneous decrease in [Hb] and V˙O2max (Fig. 4). The opposite effect is achieved in settings of blood transfusion and strong erythropoiesis due to recombinant human erythropoietin (rhEPO) administration. As indicated in Figure 4, mean data from antidoping studies show a similar relationship between changes in [Hb] and changes in V˙O2max, as observed after blood loss.
In both of these nonphysiological conditions, the change in tHb-mass exerts its effects on V˙O2max via a change in O2 transport capacity, that is, [Hb], whereas cardiac output is only marginally affected (18).
The slope of the regression line between tHb-mass and V˙O2max in the settings of blood loss and erythropoietic stimulation confirms that the change of 1 g hemoglobin is related to a change in V˙O2max of approximately 4 mL·min−1, independent of the mechanism, that is, CO or O2 transport capacity.
EFFECTS OF TRAINING ON THb-MASS AND [Hb]
Because elite endurance athletes possess 40%-50% higher tHb-mass, training is assumed to stimulate erythropoiesis. Data from the literature, however, are very inconsistent. Training studies lasting 4-12 wk and referring to methods using markers of red cells or hemoglobin show no increase. Those studies, however, using Evans Blue as a marker of plasma proteins and subsequently calculating red cell mass found increases between 8% and 12% after 3 and 12 wk of training, respectively ((34); for review, see (31)). Because the accuracy of the Evans Blue method for the determination of red cell volume or tHb-mass is by far lower than those methods using markers for red cells or hemoglobin (11), these latter results have to be regarded with caution. In the longest conducted training study in the literature using carbon monoxide as a marker of hemoglobin, we recently observed a 6.4% increase in tHb-mass (+60 g) in moderately trained runners (V˙O2max = 53.1 mL·min−1·kg−1), following an intensive 9-month marathon training program ((31); Fig. 5). During this training period, V˙O2max increased by 250 mL·min−1, which again confirms the dependency of V˙O2max on tHb-mass by approximately 4 mL·min−1 per 1 g hemoglobin. Although tHb-mass significantly increased after the training program, the absolute value (12.5 g·kg−1) did not come up to the values reported for elite marathon runners (>14.5 g·kg−1; (13)), indicating that maximum tHb-mass levels can only be reached by either years of intensive training or is strongly influenced by genetic parameters. The latter point of view is supported by the identification of high V˙O2max (65.0 mL·min−1·kg−1) levels in subjects with high blood volume (92.3 mL·kg−1) and tHb-mass (13.8 g·kg−1) without any training history (19). The insensitivity of the erythropoietic system to training also is mirrored by the very low oscillations of tHb-mass during a training year (1.8 ± 3.8%), including periods of recovery and high level competitions (24). Therefore, we concluded that training is not a significant factor in altering tHb-mass.
The adaptation of blood to training is not a simple reaction to frequent periods of high oxygen demand in the muscle. In the kidney, where oxygen availability is sensed, arterial oxygen partial pressure is likely not decreased. Exercise-induced reductions in renal perfusion and oxygen supply may be completely compensated by reductions in renal oxygen consumption because of lower sodium reabsorption and a right-shifted oxygen dissociation curve, which improves oxygen supply to the tissue. As a consequence, erythropoietin concentration ([EPO]) remains constant after exercise at different intensities and durations (27).
The small adaptation in tHb-mass to long-term training may be mediated by adjustments in blood volume to a new set point and a slow and only partially occurring recovery of the individual characteristic [Hb] by an increase in tHb-mass (Fig. 6, arrow a). This behavior can be observed in the above-mentioned training study in which tHb-mass increased by 6.4% after 9 months, whereas [Hb] did not completely recover during that time (31). In this case, [Hb] should have decreased from 15.2 g·dL−1 to 13.8 g·dL−1 as a result of plasma volume expansion; however, because of the increased tHb-mass production, [Hb] only dropped to 14.7 g·dL−1 (Fig. 5).
Repeated intensive endurance efforts are accompanied by plasma volume overcompensation reaching up to approximately 1000 mL during the Tour de France ((20); Fig. 6, arrow p). Despite a transient overshoot in plasma volume and herewith reduced [Hb], the erythropoietic activity is not increased, and tHb-mass does not change in these situations.
On the other hand, there is evidence from blood withdrawal and blood retransfusion studies that the volume regulating system quickly reconstitutes the normal individual blood volume, which is followed by normalization of [Hb]. Blood withdrawal leads to a decrease in [Hb] because of a rapid expansion of plasma volume compensating for the loss of blood volume and a delayed and slow increase in tHb-mass until the original [Hb] is attained again within 30 d ((22); Figs. 4 and 6, arrows b and c). In contrast, in blood transfusion studies, the erythropoietic system is suppressed within 21 d after transfusion, as indicated by a decrease in reticulocyte count, until the individual [Hb] and tHb-mass is restored ((5); Fig. 6, arrows n and o).
We conclude that endurance training is only a small and slow stimulus for the erythropoietic adaptation and is not the main reason for the high endurance performance observed in elite athletes.
The long-term training adaptation seems to be in contrast to the acute exercise-induced hemoconcentration. This hemoconcentration is due to fluid loss from the intravascular space to the intracellular and interstitial spaces as well as a transient red cell expulsion from the spleen (Fig. 6, arrow d). The intended aim of all these mechanisms may be a combined effect of blood volume expansion and hemodilution due to long-term training and an acute hemoconcentration during exercise resulting in both increased blood volume and cardiac output and increased [Hb], that is, elevated O2-transport capacity. This adaptation process would be equivalent to that of other mammals, for example, horses and dogs. While exercising, these mammals release red cells from the spleen and achieve significantly different hematocrit levels during exercise (∼60%) and at rest (∼35%) (2). The increased muscle oxygen supply is provided during periods of demand, whereas a low hematocrit, which favors the protection against thrombotic risk factors, occurs at rest.
The magnitude of this mechanism is illustrated by the following example: when [Hb] raises from 15.0 g·dL−1 to 16.5 g·dL−1 in an athlete with 7500 mL of blood and 1025 g hemoglobin (Fig. 1), an increase in [Hb] up to 0.5 g·dL−1 is a result of splenic release (66 g in 200 mL of red cells) and greater than 1.0 g·dL−1 is due to the transient loss of 500 mL of plasma volume. The resulting decrease in blood volume (from 7700 mL to 7200 mL) reduces cardiac output by 1.25 L and V˙O2max by approximately 150 mL·min−1; on the other hand, the increase in [Hb] augments V˙O2max by approximately 300 mL·min−1 and compensates for the lower cardiac output.
In conclusion, the combined effect of long-term training and acute exercise promotes high cardiac output due to a chronically increased blood volume and elevated [Hb] due to an acute reduction of plasma volume.
EFFECTS OF ALTITUDE ON tHb-MASS AND [Hb]
The regulation processes of tHb-mass and [Hb] at altitude are completely different to those occurring during endurance training at sea level. When commuting from lowlands to altitude, [Hb] increases to maintain an adequate avDO2. This adjustment is achieved by a reduction in plasma volume occurring within hours to a few days (Fig. 6, arrow e). Within the following weeks to months at altitude, plasma volume remains low, whereas tHb-mass increases until the initial blood volume is achieved ((12); Fig. 6, arrow f). The end stage of this adaptation process can be observed in natives of the Andes ((12); Fig. 6, arrow g), who display high tHb-mass, low plasma volume, and elevated [Hb]. The magnitude of the increase in tHb-mass and [Hb] is related to the prevailing altitude. For example, the tHb-mass and [Hb] are 11% and 2.3 g·dL−1 higher at 2600 m and 14% and 3.1 g·dL−1 at 3500 m compared with lowlanders, respectively (3,12).
Interestingly, altitude populations with a long adaptation history (i.e., at least 20,000 yr in Tibetans and East Africans in comparison to less than 5000 yr in the Andeans) are characterized by a similar [Hb] as populations from lowlands (1), indicating different adaptation processes (Fig. 6, arrow h).
The erythropoietic stimulation at altitude also differs from that during training. Although no change in plasma [EPO] occurs after exercise or during training periods (27), [EPO] increases transiently for some days after ascent to altitude because of the lower blood oxygen saturation in the kidney (8). After several days at altitude, [EPO] decreases and reaches a constant level slightly above the initial baseline.
EFFECTS OF TRAINING AT ALTITUDE (HYPOXIA) ON THb-MASS AND [Hb]
Recent research efforts in the area of altitude training and endurance performance have focused on the concept of "live high-train low" (17,10). Basing from a critical evaluation of the literature, we concluded that those altitude training studies, which were performed for at least 3 wk at altitudes above 2100 m, but with less than 14 h of hypoxia per day, did not show any increases in tHb-mass. In contrast, the studies in which the subjects were exposed to similar hypoxic conditions for at least 14 h·day−1 reported increases in tHb-mass of approximately 6% (Fig. 6, arrow f). This magnitude is comparable to the effects achieved when performing conventional altitude training (Fig. 7; (31)).
The maximum tHb-mass ever determined in endurance athletes is derived from cyclists native to altitude living and training at 2600 m. They combine training and hypoxia-induced stimuli (Fig. 6, arrows g and i) and possess approximately 70% more hemoglobin than sedentary subjects from sea level. However, in these athletes, [Hb] concentration is lower compared with that in untrained subjects from the same altitude reflecting blood volume expansion, similar to what occurs at sea level (29).
In many of the altitude training studies conducted above 2000 m, positive effects on V˙O2max and performance at sea level were demonstrated (for review, see (7)). The V˙O2max response to altitude, however, was rather individual, and no clear relationship was observed between tHb-mass and V˙O2max. The mechanisms leading to this benefit several days or weeks after return to sea level have not been clarified. It has not been determined whether increased [Hb] due to elevated tHb-mass or an increased blood volume due to plasma volume expansion after return from altitude exert more influence on V˙O2max (Fig. 6, arrows f or k).
While at sea level, an increase in tHb-mass is accompanied by improved V˙O2max, this relationship is not present at altitude. Despite 11% higher tHb-mass after 6 months of intermittent acclimatization to 3500 m, no difference in V˙O2max could be observed compared with the matched controls at similar altitude (23). Also, infusion of 700 mL red cells in saline (∼100 g hemoglobin) during acute exposure to 4300 m did not prevent the reduction in V˙O2max (−26%), which was identical to the drop in a nontreated control group (35). These data are in accordance with calculations of Wagner (33) demonstrating that muscle and lung diffusion capacity as well as ventilation but not cardiac output and [Hb] are the limiting factors at higher altitudes.
EFFECTS OF DOPING ON tHb-MASS AND [Hb]
The magnitude of blood doping expressed as a change in tHb-mass occurring in competing elite athletes has never been published. Controlled antidoping studies investigating the effects of rhEPO and obvious cases of blood doping show increases in tHb-mass of approximately 10%. The total blood volume is not affected by rhEPO administration (18,21) and only slightly elevated by the combined effect of rhEPO administration and training ((28); Fig. 6, arrows l and m). The positive impact on V˙O2max can therefore be attributed to an increase in [Hb] and not to an increased cardiac output (18).
In the mid-1990s, hematocrit values frequently oscillated by more than 10% during cycling seasons. Using published data from the internet of cyclists from the Gewiss-Ballan team from December 1994 and May 1995 (hematocrit (Hct) increased from 41.1 ± 2.4% to 53.7 ± 3.8%) and assuming that they have a mean blood volume of 7574 mL (nonmanipulated state as shown for elite cyclists (28)), tHb-mass increased by approximately 285 g, which corresponds to a hemoglobin content of 4 blood bags. After the introduction of cutoff limits (e.g., Hct 50% in cycling, [Hb] 17.0 g·dL−1 in cross-country skiing), excessively high values disappeared, but mean [Hb] of the athletes increased. In a study conducted in 1999, we showed that more than 50% of the riders from a professional cycling team increased their tHb-mass by more than 100 g (28) during one season, which cannot represent a physiological adaptation to training (24). From antidoping studies, it is known that such an increase can be obtained only by a 24-d administration period of rhEPO (21). After introducing the rhEPO detection method, many athletes switched to autologous blood transfusions, which allows for similar changes in tHb-mass as obtained by rhEPO administration.
Despite the introduction of cutoff limits, the magnitude of blood manipulations is considerable. Assuming a hematocrit of 44% in the nonmanipulated state (corresponding to a [Hb] of 14.5 g·dL−1), a blood volume of 7500 mL, and a tHb-mass of 990 g, the critical Hct of 50% ([Hb] of ∼16.5 g·dL−1) is reached after the administration of 136 g hemoglobin, that is, the hemoglobin content of two blood bags (Fig. 6, arrows n and o). More extreme forms of manipulation are possible during stage races because plasma volume overcompensation in the range of 1000 mL (see section "Effects of Training on tHb-mass and [Hb]") reduces [Hb] and Hct values and herewith increases the scope of action (Fig. 6, arrow p).
Changes in tHb-mass due to blood doping are not uniformly reflected by changes in [Hb]. The impact of tHb-mass expansion exerts higher [Hb] in athletes with low blood volumes compared with those with higher volumes. For instance, when transfusing 120 g of hemoglobin to a small female athlete with 4 L of blood, [Hb] increases by 3.3 g·dL−1 (e.g., from 14.0 to 17.3 g·dL−1). When transfusing the same amount of hemoglobin to a tall male athlete with a blood volume of 9 L, [Hb] increases only 1.5 g·dL−1 (e.g., from 15.0 to 16.5 g·dL−1). In both cases, however, the increase of 120 g augments V˙O2max by approximately 400 mL·min−1 (Fig. 4). This magnitude of improved performance has been observed after 24 days of rhEPO administration (21). When extrapolating this relationship between V˙O2max and tHb-mass, we calculate a benefit in V˙O2max of up to 1000 mL·min−1 for the times before the cutoff limits (Hct 50%) were introduced and of up to 860 mL·min−1 in riders with hematocrit values close to 50% at the end of a 3-wk stage race.
tHb-mass determines V˙O2max via two different mechanisms. V˙O2max can be increased by the following: (i) a balanced increase of tHb-mass and plasma volume augmenting cardiac output and/or (ii) by increasing [Hb] due to an increase of tHb-mass accompanied by a reduced or unchanged plasma volume augmenting avDO2. Mechanism (i) is achieved by endurance training; mechanism (ii), by adaptation to altitude or blood manipulation. A combination of both mechanisms is present in athletes training and living at altitude and also, but to a lesser extent, in endurance athletes from sea level during acute exercise. However, the highest impact on V˙O2max is obtained when athletes increase [Hb] by blood manipulation (Fig. 7). A change in tHb-mass by 1 g causes a change in V˙O2max by approximately 4 mL·min−1.
This research was supported in part by the World Anti-Doping Agency and the Federal Institute of Sports Sciences Germany (BISp).
1. Beall CM. Two routes to functional adaptation: Tibetan and Andean high-altitude
natives. Proc. Natl. Acad. Sci. U. S. A.
2. Böning D, Maassen N. Mechanisms of doping with erythropoietin. Dtsch. Ztschr. Sportmed.
3. Böning D, Rojas J, Serrato M, et al. Hemoglobin mass and physical training
in male and female residents of moderate altitude
. Int. J. Sports Med
. 2002; 23:79-80.
4. Burge CM, Skinner SL. Determination of hemoglobin mass and blood volume
with CO: evaluation and application of a method. J. Appl. Physiol
. 1995; 79(2):623-31.
5. Damsgaard R, Munch T, Mørkeberg J, Mortensen SP, González-Alonso J. Effects of blood withdrawal and reinfusion on biomarkers of erythropoiesis in humans: implications for anti-doping strategies. Haematologica
. 2006; 91:1006-8.
6. Ekblom B. Effect of physical training
on oxygen transport system in man. Acta. Physiol. Scand
. 1969; S:1-45.
7. Friedmann-Bette B. Classical altitude training
. Scand. J. Med. Sci. Sports
2008; 18(Suppl. 1):11-20.
8. Ge R-L, Witkowski S, Zhang Y, et al. Determinants of erythropoietin release in response to short-term hypobaric hypoxia. J. Appl. Phys
. 2002; 92:2361-7.
9. Gore CJ, Hahn AG, Burge CM, Telford RD. V˙O2max
and haemoglobin mass of trained athletes during high intensity training
. Int. J. Sports Med
. 1997; 18:477-82.
10. Gore CJ, Hopkins WG. Counterpoint: positive effects of intermittent hypoxia (live high:train low) on exercise performance are not mediated primarily by augmented red cell volume. J. Appl. Physiol
. 2005; 99(5):2055-7.
11. Gore CJ, Hopkins WG, Burge CM. Errors of measurement for blood volume
parameters: a meta-analysis. J. Appl. Physiol
. 2005; 99:1745-58.
12. Heinicke K, Prommer N, Cajigal J, Viola T, Behn C, Schmidt W. Long-term exposure to intermittent hypoxia results in increased hemoglobin mass, reduced plasma volume, and elevated erythropoietin plasma levels in man. Eur. J. Appl. Physiol
. 2003; 88:535-43.
13. Heinicke K, Wolfahrt B, Winchenbach P, et al. Blood volume
and hemoglobin mass in elite athletes of different disciplines. Int. J. Sports Med
. 2001; 22:504-12.
14. Horwitz L, Lindenfeld J. Effects of enhanced ventricular filling on cardiac pump performance in exercising dogs. J. Appl. Physiol
. 1985; 59(6):1886-90.
15. Kanstrup IL, Ekblom B. Blood volume
and hemoglobin concentration
as determinants of maximal aerobic power. Med. Sci. Sports Exerc
. 1984; 16(3):256-62.
16. Levine BD. V˙O2max
: what do we know, and what do we still need to know? J. Physiol
. 2008; 586(1):25-34.
17. Levine BD, Stray-Gundersen J. Point: positive effects of intermittent hypoxia (live high:train low) on exercise performance are mediated primarily by augmented red cell volume. J. Appl. Physiol
. 2005; 99(5):2053-5.
18. Lundby C, Thomsen JJ, Boushel R, et al. Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volume. J. Physiol
. 2007; 578(1):309-14.
19. Martino M, Gledhill N, Jamnik V. High V˙O2max
with no history of training
is primarily due to high blood volume
. Med. Sci. Sports Exerc
. 2002; 34(6):966-71.
20. Morkeberg JS, Belhage B, Damsgaard R. Changes in blood values in elite cyclist. Int. J. Sports Med
. 2009; 30(2):130-8.
21. Parisotto R, Gore CJ, Emslie KR, et al. A novel method utilizing markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. Haematologica
22. Prommer N, Heckel A, Schmidt W. Timeframe to detect blood withdrawal associated with autologous blood doping. Med. Sci. Sports Exerc
. 2007; 39(5 Suppl):S3.
23. Prommer N, Heinicke K, Viola T, Cajigal J, Behn C, Schmidt WFJ. Long-term intermittent hypoxia increases O2
-transport capacity but not V˙O2max
. High Alt. Med. Biol
. 2007; 8(3):225-35.
24. Prommer N, Sottas P-E, Schoch C, Schumacher YO, Schmidt W. Total hemoglobin mass-a new parameter to detect blood doping. Med. Sci. Sports Exerc
. 2008; 40(12):2112-8.
25. Rowell LB. Ideas about control of skeletal and cardiac muscle blood flow (1876-2003): cycles of revision and new vision. J. Appl. Physiol.
26. Sawka MN, Young AJ, Pandolf KB, Dennis RC, Valeri CR. Erythrocyte, plasma and blood volume
of healthy young men. Med. Sci. Sports Exerc.
27. Schmidt W, Eckardt KU, Hilgendorf A, Strauch S, Bauer C. Effects of maximal and submaximal exercise under normoxic and hypoxic conditions on serum erythropoietin level. Int. J. Sports Med.
28. Schmidt W, Heinicke K. Screening of total hemoglobin mass in triathletes and professional cyclists. Dtsch. Ztschr. Sportmed.
29. Schmidt W, Heinicke K, Rojas J, et al. Blood volume
and hemoglobin mass in endurance athletes from moderate altitude
. Med. Sci. Sports Exerc
. 2002; 34(12):1934-40.
30. Schmidt W, Prommer N. The optimised CO-rebreathing method: a new tool to determine total haemoglobin mass routinely. Eur. J. Appl. Physiol
. 2005; 95:486-95.
31. Schmidt W, Prommer N. Effects of various training
modalities on blood volume
. Scand. J. Med. Sci. Sports
2008; 18(Suppl. 1):57-69.
32. Schmidt WF, Doerfler C, Wachsmuth N, et al. Influence of body mass, body composition, and performance state on total hemoglobin mass. Med. Sci. Sports Exerc.
33. Wagner PD. New ideas on limitations to V˙O2max
. Exerc. Sport Sci. Rev.
34. Warburton DE, Haykowski MJ, Quinney HA, et al. Blood volume
expansion and cardiorespiratory function: effects of training
modality. Med. Sci. Sports Exerc.
35. Young AJ, Sawka MN, Muza SR, et al. Effects of erythrocyte infusion on V˙O2max
at high altitude
. J. Appl. Physiol.